Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bone Marrow Transplantation|August 1, 1993
HIV infection after autologous bone marrow transplantation despite HIV-antibody and HIV-antigen screeningS Jootar, P Angchaisuksiri, P Chiewsilp, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|June 1, 1993
Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxoneP Suwangool, N Aswapokee, B Sathapatayavongs, et al.
British Journal of Haematology|July 1, 1993
Chronic administration of transforming growth factor-beta suppresses erythropoietin-dependent erythropoiesis and induces tumour necrosis factor in vivoS Chuncharunee, C D Carter, K E Studtmann, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|June 24, 2000
Etiology and incidence of thrombotic and hemorrhagic disorders in Thai patients with extreme thrombocytosisS Chuncharunee, N Archararit, A Ungkanont, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|November 5, 1997
Levels of serum tumor necrosis factor alpha in relation to clinical involvement and treatment among Thai adults with Plasmodium falciparum malariaS Chuncharunee, S Jootar, A Leelasiri, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 29, 2009
Bioequivalence study of a film-coated tablet of deferiprone in healthy Thai volunteersN P Morales, L, P Yamanont, et al.
Hematology (Amsterdam, Netherlands)|April 14, 2017
Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patientsN Limsuwanachot, B Rerkamnuaychoke, S Chuncharunee, et al.
The Journal of International Medical Research|October 2, 2004
Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritisT Sundrarjun, S Komindr, N Archararit, et al.
International Journal of Hematology|October 12, 2001
Treatment of myelodysplastic syndrome with low-dose human granulocyte colony-stimulating factor: a multicenter studyS Chuncharunee, T Intragumtornchai, B Chaimongkol, et al.
Pageof 2